NON-SEGMENTAL VITILIGO
Clinical trials for NON-SEGMENTAL VITILIGO explained in plain language.
Never miss a new study
Get alerted when new NON-SEGMENTAL VITILIGO trials appear
Sign up with your email to follow new studies for NON-SEGMENTAL VITILIGO, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for vitiligo: experimental drug aims to bring back skin color
Disease control Recruiting nowThis study tests an experimental drug called GIA632 in 210 adults with non-segmental vitiligo, a condition that causes white patches on the skin. The goal is to see if the drug can safely restore skin color and to find the best dose for future studies. Participants will receive e…
Matched conditions: NON-SEGMENTAL VITILIGO
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New drug aims to restore skin color in vitiligo patients
Disease control Recruiting nowThis study tests whether a new drug called EI-001 can help people with vitiligo, a condition that causes white patches on the skin. The drug works by calming the immune system to reduce inflammation. About 45 adults with nonsegmental vitiligo will receive either EI-001 or a place…
Matched conditions: NON-SEGMENTAL VITILIGO
Phase: PHASE2 • Sponsor: Elixiron Immunotherapeutics (Hong Kong) Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Could a pill and gel combo restore skin color in vitiligo?
Disease control Recruiting nowThis study tests a new drug called SHR0302, given as a tablet and a gel, for people with non-segmental vitiligo. The goal is to see if it can safely and effectively bring back skin color. About 176 adults aged 18 to 75 will take part, and some will receive a placebo to compare re…
Matched conditions: NON-SEGMENTAL VITILIGO
Phase: PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New pill aims to recolor white patches in vitiligo patients
Disease control Recruiting nowThis study tests a new drug called VC005 in 120 adults with non-segmental vitiligo, a condition that causes white patches on the skin. Participants will take either VC005 or a placebo daily for 52 weeks. The main goal is to see if the drug can reduce the size of white patches on …
Matched conditions: NON-SEGMENTAL VITILIGO
Phase: PHASE2 • Sponsor: Jiangsu vcare pharmaceutical technology co., LTD • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Poking skin to bring back color: which needle works best for vitiligo?
Disease control Recruiting nowThis study tests two ways of puncturing white patches of skin—using a single needle or a microneedling device—followed by UV light therapy to see which helps restore pigment better. Eighty adults with stable non-segmental vitiligo will receive six sessions over 24 weeks. The goal…
Matched conditions: NON-SEGMENTAL VITILIGO
Phase: PHASE4 • Sponsor: Khyber Teaching Hospital • Aim: Disease control
Last updated Jun 26, 2026 13:18 UTC